Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Official title: “To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.”
What this law changes
Not startedPlain-language account: Not started
Transparency Score
The Transparency Score is the share of this law’s dollars that goes to what the law says it is for. We have not read this law for this section yet.
What this law changes in taxes
We have not read this law for this section yet.
Press releases by members of Congress
No saved press release names this law.
Read from 539 of 539 members' sites, releases since January 3, 2025, through October 8, 2026.
Press releases by organizations
No saved press release from these organizations names this law.
Read from 510 of 510 organizations' sites, releases since January 3, 2025, through October 8, 2026.
How it passed
The Senate passed it by voice vote on October 11, 2018. A voice vote records no individual votes.
The House passed it by voice vote on December 11, 2018. A voice vote records no individual votes.
It became law on December 18, 2018.
How each member votes
Both chambers passed this law without a recorded vote, so no individual votes exist.
Where this comes from
A file marked "saved" is our own copy of the official file. The code beside it is its fingerprint, a short code that changes if the file's contents change. A file with no copy saved carries "Not published yet".